Advisory Committee on Childhood Lead Poisoning Prevention (ACCLPP), National Center for Environmental Health (NCEH), 38600 [E7-13596]
Download as PDF
<![CDATA[
38600
Federal Register / Vol. 72, No. 134 / Friday, July 13, 2007 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Respondents
Laboratory Test Result Form .................................................................................................
Dated: July 9, 2007.
Maryam Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–13605 Filed 7–12–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Childhood
Lead Poisoning Prevention (ACCLPP),
National Center for Environmental
Health (NCEH)
pwalker on PROD1PC71 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting of the
aforementioned committee:
Times and Dates:
8:30 a.m.–5 p.m., September 18, 2007.
8:30 a.m.–12:30 p.m., September 19, 2007.
Place: Radisson Plaza Hotel Minneapolis,
35 South 7th Street, Minneapolis, MN 55402,
Telephone: (612) 339–4900.
Open to the public, limited only by the
space available. The meeting room
accommodates approximately 75 people.
Purpose: The Committee provides advice
and guidance to the Secretary; the Assistant
Secretary for Health; and the Director, CDC,
regarding new scientific knowledge and
technological developments and their
practical implications for childhood lead
poisoning prevention efforts. The Committee
also reviews and reports regularly on
childhood lead poisoning prevention
practices and recommends improvements in
national childhood lead poisoning
prevention efforts.
Matters To Be Discussed: The meeting will
include discussion on the potential
approaches to strengthen existing strategies
to achieve the Healthy People 2010 goal of
eliminating Elevated Blood Lead Levels as a
Public Health Problem in the United States
by 2010, the development of a prevention
based research agenda, and the study designs
related to adverse effects from Blood Lead
Levels (BLLs) < 10 µg/dl; and updates on the
school performance and concurrent BLLs.
Agenda items are subject to change as
priorities dictate.
Opportunities will be provided during the
meeting for oral comments. Depending on the
time available and the number of requests, it
may be necessary to limit the time of each
presenter.
VerDate Aug<31>2005
19:05 Jul 12, 2007
Jkt 211001
Contact Person for More Information:
Claudine Johnson, Clerk, Lead Poisoning
Prevention Branch, Division of
Environmental Emergency Health Services,
NCEH, CDC, 4770 Buford Hwy, NE., Mailstop
F–40, Atlanta, GA 30341, Telephone (770)
488–3629, Fax (770) 488–3635.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: July 6, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–13596 Filed 7–12–07; 8:45 am]
BILLING CODE 4163–18–P
Number of
responses per
respondent
754
Average burden
per response
(in hours)
2
10/60
evaluation of research grant applications in
response to RFA DP07–707, ‘‘Racial and
Ethnic Approaches to Community Health
Across the United States (REACH US).’’
For Further Information Contact: Thijuanie
Lockhart, Program & Management Analyst,
CDC, 4770 Buford Highway, NE., Mail Stop
K–30, Atlanta, GA 30341, Telephone (404)
488–5303.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: July 9, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–13602 Filed 7–12–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Racial and Ethnic
Approaches to Community Health
Across the United States (REACH US),
Request for Applications (RFA) DP07–
707
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Public Law 92–463), the Centers for
Disease Control and Prevention (CDC)
announces a meeting of the
aforementioned Special Emphasis
Panel.
Times and Dates: 3 p.m.–8 p.m., July 31,
2007 (Closed), 8 a.m.–5 p.m., August 1, 2007
(Closed), 8 a.m.–5 p.m., August 2, 2007
(Closed), 3 p.m.–8 p.m., August 6, 2007
(Closed), 8 a.m.–5 p.m., August 7, 2007
(Closed), 8 a.m.–5 p.m., August 8, 2007
(Closed), 8 a.m.–5 p.m., August 9, 2007
(Closed).
Place: Sheraton Gateway Hotel Atlanta
Airport, 1900 Sullivan Road, Atlanta, GA
30337, Telephone (800) 454–6835.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Pub. L. 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–67776, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 72 FR 35491–35492,
dated June 28, 2007) is amended to
reflect the establishment of the
Extramural Research Program Office
within the National Center for Chronic
Disease Prevention and Health
Promotion, Coordinating Center for
Health Promotion, Centers for Disease
Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows: After the functional statement
for the Program Services Branch
(CUC13), Office of the Director (CUC1),
National Center for Chronic Disease
Prevention and Health Promotion
(CUC), insert the following:
Extramural Research Program Office
(CUC18). The Extramural Research
Program Office (ERPO) plans, develops,
E:\FR\FM\13JYN1.SGM
13JYN1
]]>Agencies
[Federal Register Volume 72, Number 134 (Friday, July 13, 2007)]
[Notices]
[Page 38600]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-13596]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Childhood Lead Poisoning Prevention
(ACCLPP), National Center for Environmental Health (NCEH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following meeting of the aforementioned
committee:
Times and Dates:
8:30 a.m.-5 p.m., September 18, 2007.
8:30 a.m.-12:30 p.m., September 19, 2007.
Place: Radisson Plaza Hotel Minneapolis, 35 South 7th Street,
Minneapolis, MN 55402, Telephone: (612) 339-4900.
Open to the public, limited only by the space available. The
meeting room accommodates approximately 75 people.
Purpose: The Committee provides advice and guidance to the
Secretary; the Assistant Secretary for Health; and the Director,
CDC, regarding new scientific knowledge and technological
developments and their practical implications for childhood lead
poisoning prevention efforts. The Committee also reviews and reports
regularly on childhood lead poisoning prevention practices and
recommends improvements in national childhood lead poisoning
prevention efforts.
Matters To Be Discussed: The meeting will include discussion on
the potential approaches to strengthen existing strategies to
achieve the Healthy People 2010 goal of eliminating Elevated Blood
Lead Levels as a Public Health Problem in the United States by 2010,
the development of a prevention based research agenda, and the study
designs related to adverse effects from Blood Lead Levels (BLLs) <
10 [mu]g/dl; and updates on the school performance and concurrent
BLLs.
Agenda items are subject to change as priorities dictate.
Opportunities will be provided during the meeting for oral
comments. Depending on the time available and the number of
requests, it may be necessary to limit the time of each presenter.
Contact Person for More Information: Claudine Johnson, Clerk,
Lead Poisoning Prevention Branch, Division of Environmental
Emergency Health Services, NCEH, CDC, 4770 Buford Hwy, NE., Mailstop
F-40, Atlanta, GA 30341, Telephone (770) 488-3629, Fax (770) 488-
3635.
The Director, Management Analysis and Services Office has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: July 6, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-13596 Filed 7-12-07; 8:45 am]
BILLING CODE 4163-18-P
